| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,512 |
15,201 |
$759K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,014 |
18,477 |
$609K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12,050 |
11,863 |
$205K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,394 |
3,366 |
$168K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,539 |
2,519 |
$156K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,359 |
3,334 |
$142K |
| G9920 |
Screening performed and negative |
3,540 |
3,528 |
$110K |
| 97802 |
|
3,337 |
3,274 |
$110K |
| D1206 |
Topical application of fluoride varnish |
4,433 |
4,388 |
$105K |
| 92551 |
|
6,601 |
6,537 |
$78K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,474 |
1,450 |
$57K |
| 99401 |
|
2,611 |
2,604 |
$50K |
| 99215 |
Prolong outpt/office vis |
335 |
318 |
$23K |
| 99173 |
|
5,884 |
5,831 |
$20K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
223 |
221 |
$15K |
| 81002 |
|
5,342 |
5,296 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,758 |
1,741 |
$12K |
| 99188 |
|
537 |
533 |
$11K |
| 92552 |
|
457 |
448 |
$8K |
| 96127 |
|
1,023 |
1,020 |
$5K |
| 90651 |
|
1,074 |
1,064 |
$5K |
| 90670 |
|
1,438 |
1,415 |
$4K |
| 90716 |
|
967 |
951 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
52 |
52 |
$3K |
| 90734 |
|
751 |
751 |
$3K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
63 |
63 |
$2K |
| 90707 |
|
816 |
802 |
$2K |
| 90686 |
|
2,535 |
2,529 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
15 |
15 |
$1K |
| 90621 |
|
153 |
152 |
$1K |
| 90698 |
|
767 |
749 |
$1K |
| 90715 |
|
510 |
509 |
$961.43 |
| 90680 |
|
604 |
589 |
$764.09 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
37 |
36 |
$523.86 |
| 90697 |
|
90 |
90 |
$495.47 |
| 90696 |
|
228 |
225 |
$452.01 |
| G9919 |
Screening performed and positive and provision of recommendations |
14 |
14 |
$414.70 |
| 90633 |
|
802 |
798 |
$348.40 |
| 90744 |
|
394 |
388 |
$252.71 |
| 90700 |
|
195 |
191 |
$159.02 |
| 90685 |
|
487 |
486 |
$155.84 |
| 94760 |
|
14 |
14 |
$79.95 |
| 90713 |
|
54 |
54 |
$38.21 |
| 90648 |
|
52 |
52 |
$13.54 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
34 |
34 |
$1.32 |
| 90656 |
|
58 |
58 |
$0.00 |
| 90619 |
|
13 |
13 |
$0.00 |
| 90677 |
|
21 |
21 |
$0.00 |